RxDoctor Payments DataLook up a doctor →

John Mansueti, MD

Radiation Oncology · Berlin, MDNPI 1699776955

Payments from drug & device makers

$10,602in general payments, 2019–2025

Across 260 payments — averaging $40.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • Johnson & Johnson$585
  • Beigene USA, Inc.$582
  • Bayer$522
  • E.r. Squibb & Sons, L.L.C.$494
  • Daiichi Sankyo Inc.$469
  • plus $6K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca29$1,567
Johnson & Johnson13$585
Beigene USA, Inc.7$582
Bayer10$522
E.r. Squibb & Sons, L.L.C.14$494
Daiichi Sankyo Inc.14$469
Novartis18$409
GSK7$394
Amgen9$331
Gilead(2 entities)4$322
Karyopharm Therapeutics Inc.3$319
Pharmacyclics LLC, An Abbvie Company6$312
Eisai Inc.6$311
Pfizer6$289
Merck11$283
Seagen Inc.9$281
Varian Medical Systems, Inc.3$280
Exelixis Inc.10$260
Bristol Myers Squibb8$258
Progenics Pharmaceuticals, Inc.3$251
AbbVie5$210
Sanofi5$189
Taiho Oncology, Inc.4$189
Lilly USA, LLC4$177
Jazz Pharmaceuticals Inc.2$170
Genentech USA, Inc.4$99
Puma Biotechnology, Inc.1$92
Takeda Pharmaceuticals U.S.A., Inc.4$78
Mirati Therapeutics, Inc.2$48
Incyte Corporation3$45
ADC Therapeutics America, Inc.2$41
Array Biopharma Inc2$41
Tersera Therapeutics LLC1$39
Blue Earth Diagnostics1$37
Ipsen Biopharmaceuticals, Inc2$32
Syndax Pharmaceuticals, Inc.1$32
EMD Serono, Inc.1$30
Tactile Systems Technology Inc2$29
Astellas Pharma US Inc1$29
AVEO Pharmaceuticals, Inc.1$28
Dendreon Pharmaceuticals LLC1$28
Pharmaessentia USA Corporation1$27
Stemline Therapeutics Inc.1$26
Regeneron Healthcare Solutions, Inc.1$26
Blueprint Medicines Corporation1$26
Myriad Genetic Laboratories, Inc.2$25
Immunocore Limited1$25
Teleflex LLC1$25
Novocure Inc.1$24
Kyowa Kirin, Inc.1$23
Boston Scientific1$22
Boehringer Ingelheim1$21
Servier Pharmaceuticals LLC1$19
Deciphera Pharmaceuticals Inc.1$19
Myovant Sciences Inc.1$18
Tesaro, Inc.1$17
Coherus Oncology, Inc.1$17
Alnylam Pharmaceuticals Inc.1$17
Foundation Medicine, Inc.1$17
Secura Bio, Inc.1$14

How this compares

$10,602 in reported general payments places this provider in the 80th percentile of 108 radiation oncology providers in Maryland.

See all radiation oncology providers in Maryland

Medicare billing

Part B allowed, 2024
$1,364,650
Medicare patients
456
Services billed
6,281

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other radiation oncology in Berlin

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →